SEIZMET TRIO 0.2

SEIZMET TRIO 0.2 combines three potent medications: Glimepiride (2mg), Metformin SR (500mg), and Voglibose (0.2mg). This combination is formulated to provide comprehensive management of type 2 diabetes mellitus, particularly for patients who require multiple therapies to achieve optimal blood glucose control.

How Does It Work?

• Glimepiride: Stimulates the pancreas to release insulin, which helps lower blood sugar levels.
• Metformin SR: Decreases glucose production in the liver and increases insulin sensitivity, aiding the body in using insulin more effectively.
• Voglibose: Delays glucose absorption in the intestines, preventing post-meal blood sugar spikes.

Uses of SEIZMET TRIO 0.2

• Effective management of type 2 diabetes mellitus.
• Helps in maintaining target blood sugar levels.
• Reduces the risk of diabetes-related complications.

What is SEIZMET TRIO 0.2?

SEIZMET TRIO 0.2 is an oral antidiabetic medication that combines Glimepiride, Metformin SR, and Voglibose to improve glycemic control in adults with type 2 diabetes mellitus. It is used when diet, exercise, and single-drug therapy do not provide adequate blood sugar control.

Side Effects

• Common: Nausea, diarrhea, stomach upset, dizziness, and headache.
• Serious: Hypoglycemia (low blood sugar), lactic acidosis, and allergic reactions.

Safety Information

• Before Use: Inform your doctor about any existing medical conditions, especially kidney or liver issues.
• During Use: Regularly monitor blood sugar levels.
• Avoid: Excessive alcohol consumption as it can increase the risk of lactic acidosis.
• Pregnancy/Breastfeeding: Consult your doctor before use.

If You Need More Information About  SEIZMET TRIO 0.2  Click here